| Income Statement |
| Total Revenue | 2.25M |
|
| Revenues (USD) | 2.25M |
| Cost of Revenue | 2.44M |
| Gross Profit | -188.61K |
| Operating Expenses | 3.58M |
| Research and Development Expense | 10.00K |
| Selling, General and Administrative Expense | 3.57M |
| Operating Income | -3.77M |
| Interest Expense | -50.00 |
| Net Income | -3.99M |
| Net Income Common Stock | -3.99M |
| Net Income Common Stock (USD) | -3.99M |
| Consolidated Income | -3.99M |
| Earnings per Basic Share | -0.31 |
| Earnings per Basic Share (USD) | -0.31 |
| Earnings per Diluted Share | -0.31 |
| Earning Before Interest & Taxes (EBIT) | -3.99M |
| Earning Before Interest & Taxes (USD) | -3.99M |
| Weighted Average Shares | 12.89M |
| Weighted Average Shares Diluted | 12.89M |
| Balance Sheet |
| Cash and Equivalents | 2.01M |
| Cash and Equivalents (USD) | 2.01M |
| Trade and Non-Trade Receivables | 1.60M |
| Current Assets | 6.77M |
| Property, Plant & Equipment Net | 4.20M |
| Total Assets | 11.19M |
| Debt Current | 4.06M |
| Total Debt | 5.11M |
| Current Liabilities | 18.31M |
| Debt Non-Current | 1.06M |
| Total Liabilities | 19.37M |
| Accumulated Retained Earnings (Deficit) | -116.58M |
| Shareholders Equity | -8.18M |
| Shareholders Equity (USD) | -8.18M |
| Assets Non-Current | 4.42M |
| Total Debt (USD) | 5.11M |
| Deferred Revenue | 1.54M |
| Liabilities Non-Current | 1.06M |
| Trade and Non-Trade Payables | 5.24M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 64.04K |
| Net Cash Flow from Financing | 6.52M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.65M |
| Capital Expenditure | -1.53M |
| Issuance (Purchase) of Equity Shares | 2.68M |
| Issuance (Repayment) of Debt Securities | 3.85M |
| Net Cash Flow from Investing | -1.53M |
| Net Cash Flow from Operations | -3.34M |
| Share Based Compensation | 25.51K |